OGN R&D to Revenue

Organon & Co. Common Stock · R&D to Revenue

OGN logo

OGN R&D to Revenue

Latest reported5.89%
OGN FY R&D/Revenue (3.38% → 5.89%)
High-resolution chart · PNG

OGN r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Organon & Co. Common Stock R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
5.888%
7.3247%
8.4305%
7.6288%
7.0273%
3.2149%
2.8289%
3.7333%
3.381%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.